Cipla Ltd. — Regulatory Filings 2019

Nov 18, 2019

18th November 2019

(1) BSE Ltd Surveillance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001

(2) National Stock Exchange of India Ltd Surveillance Department, Exchange Plaza, 5th floor, Plot no. C/1, G Block, Sandra Kurla Complex, Sandra (East), Mumbai- 400 051

Scrip Code: 500087

Scrip Code: CIPLA EQ

Dear Sirs,

This has reference to your email dated 18th November 2019 regarding news item appearing on www.moneycontrol.com captioned "Wockhardt: Cipla, Dr. Reddy's Labs, Carlyle & Asian Investment Fund PAG are in the fray to acquire select business segments of the company, said sources".

In this regard, we hereby inform you that the Company keeps exploring growth opportunities through organic and inorganic routes. We do not have anything concrete to comment at this stage on the article.

We reiterate that the Company follows highest standards of governance and compliance norms, and disclosures are made to the stock exchanges under applicable regulations including Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Thank you,

Yours faithfully, For Cipla Limited

Rajendra Chopra Company Secretary

Prepared by: Karan Tanna

Cipla Ltd.